Medical Care
Global Precision Oncology Market Research Report 2025
- May 05, 25
- ID: 228477
- Pages: 87
- Figures: 87
- Views: 9
The global market for Precision Oncology was valued at US$ 114460 million in the year 2024 and is projected to reach a revised size of US$ 218550 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
This report aims to provide a comprehensive presentation of the global market for Precision Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Oncology.
The Precision Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
This report aims to provide a comprehensive presentation of the global market for Precision Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Oncology.
The Precision Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Precision Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Diagnostic Laboratories
1.3.4 Healthcare Data Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Oncology Market Perspective (2020-2031)
2.2 Global Precision Oncology Growth Trends by Region
2.2.1 Global Precision Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Oncology Historic Market Size by Region (2020-2025)
2.2.3 Precision Oncology Forecasted Market Size by Region (2026-2031)
2.3 Precision Oncology Market Dynamics
2.3.1 Precision Oncology Industry Trends
2.3.2 Precision Oncology Market Drivers
2.3.3 Precision Oncology Market Challenges
2.3.4 Precision Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Oncology Players by Revenue
3.1.1 Global Top Precision Oncology Players by Revenue (2020-2025)
3.1.2 Global Precision Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Oncology Revenue
3.4 Global Precision Oncology Market Concentration Ratio
3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2024
3.5 Global Key Players of Precision Oncology Head office and Area Served
3.6 Global Key Players of Precision Oncology, Product and Application
3.7 Global Key Players of Precision Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Oncology Breakdown Data by Type
4.1 Global Precision Oncology Historic Market Size by Type (2020-2025)
4.2 Global Precision Oncology Forecasted Market Size by Type (2026-2031)
5 Precision Oncology Breakdown Data by Application
5.1 Global Precision Oncology Historic Market Size by Application (2020-2025)
5.2 Global Precision Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Oncology Market Size (2020-2031)
6.2 North America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Oncology Market Size by Country (2020-2025)
6.4 North America Precision Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Oncology Market Size (2020-2031)
7.2 Europe Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Oncology Market Size by Country (2020-2025)
7.4 Europe Precision Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Oncology Market Size (2020-2031)
8.2 Asia-Pacific Precision Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Oncology Market Size (2020-2031)
9.2 Latin America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Oncology Market Size by Country (2020-2025)
9.4 Latin America Precision Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Oncology Market Size (2020-2031)
10.2 Middle East & Africa Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Details
11.1.2 Acrivon Therapeutics Business Overview
11.1.3 Acrivon Therapeutics Precision Oncology Introduction
11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025)
11.1.5 Acrivon Therapeutics Recent Development
11.2 Bio-Serv
11.2.1 Bio-Serv Company Details
11.2.2 Bio-Serv Business Overview
11.2.3 Bio-Serv Precision Oncology Introduction
11.2.4 Bio-Serv Revenue in Precision Oncology Business (2020-2025)
11.2.5 Bio-Serv Recent Development
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Details
11.3.2 Exact Sciences Corporation Business Overview
11.3.3 Exact Sciences Corporation Precision Oncology Introduction
11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025)
11.3.5 Exact Sciences Corporation Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Precision Oncology Introduction
11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2020-2025)
11.4.5 Illumina, Inc. Recent Development
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Details
11.5.2 Invitae Corporation Business Overview
11.5.3 Invitae Corporation Precision Oncology Introduction
11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2020-2025)
11.5.5 Invitae Corporation Recent Development
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Details
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Precision Oncology Introduction
11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025)
11.6.5 Laboratory Corporation of America Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Precision Oncology Introduction
11.7.4 QIAGEN Revenue in Precision Oncology Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Rain Oncology
11.8.1 Rain Oncology Company Details
11.8.2 Rain Oncology Business Overview
11.8.3 Rain Oncology Precision Oncology Introduction
11.8.4 Rain Oncology Revenue in Precision Oncology Business (2020-2025)
11.8.5 Rain Oncology Recent Development
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Details
11.9.2 Relay Therapeutics Business Overview
11.9.3 Relay Therapeutics Precision Oncology Introduction
11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2020-2025)
11.9.5 Relay Therapeutics Recent Development
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Details
11.10.2 Strata Oncology, Inc. Business Overview
11.10.3 Strata Oncology, Inc. Precision Oncology Introduction
11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025)
11.10.5 Strata Oncology, Inc. Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Details
11.12.2 Variantyx, Inc. Business Overview
11.12.3 Variantyx, Inc. Precision Oncology Introduction
11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025)
11.12.5 Variantyx, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Precision Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Diagnostic Laboratories
1.3.4 Healthcare Data Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Oncology Market Perspective (2020-2031)
2.2 Global Precision Oncology Growth Trends by Region
2.2.1 Global Precision Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Oncology Historic Market Size by Region (2020-2025)
2.2.3 Precision Oncology Forecasted Market Size by Region (2026-2031)
2.3 Precision Oncology Market Dynamics
2.3.1 Precision Oncology Industry Trends
2.3.2 Precision Oncology Market Drivers
2.3.3 Precision Oncology Market Challenges
2.3.4 Precision Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Oncology Players by Revenue
3.1.1 Global Top Precision Oncology Players by Revenue (2020-2025)
3.1.2 Global Precision Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Oncology Revenue
3.4 Global Precision Oncology Market Concentration Ratio
3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2024
3.5 Global Key Players of Precision Oncology Head office and Area Served
3.6 Global Key Players of Precision Oncology, Product and Application
3.7 Global Key Players of Precision Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Oncology Breakdown Data by Type
4.1 Global Precision Oncology Historic Market Size by Type (2020-2025)
4.2 Global Precision Oncology Forecasted Market Size by Type (2026-2031)
5 Precision Oncology Breakdown Data by Application
5.1 Global Precision Oncology Historic Market Size by Application (2020-2025)
5.2 Global Precision Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Oncology Market Size (2020-2031)
6.2 North America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Oncology Market Size by Country (2020-2025)
6.4 North America Precision Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Oncology Market Size (2020-2031)
7.2 Europe Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Oncology Market Size by Country (2020-2025)
7.4 Europe Precision Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Oncology Market Size (2020-2031)
8.2 Asia-Pacific Precision Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Oncology Market Size (2020-2031)
9.2 Latin America Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Oncology Market Size by Country (2020-2025)
9.4 Latin America Precision Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Oncology Market Size (2020-2031)
10.2 Middle East & Africa Precision Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Details
11.1.2 Acrivon Therapeutics Business Overview
11.1.3 Acrivon Therapeutics Precision Oncology Introduction
11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025)
11.1.5 Acrivon Therapeutics Recent Development
11.2 Bio-Serv
11.2.1 Bio-Serv Company Details
11.2.2 Bio-Serv Business Overview
11.2.3 Bio-Serv Precision Oncology Introduction
11.2.4 Bio-Serv Revenue in Precision Oncology Business (2020-2025)
11.2.5 Bio-Serv Recent Development
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Details
11.3.2 Exact Sciences Corporation Business Overview
11.3.3 Exact Sciences Corporation Precision Oncology Introduction
11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025)
11.3.5 Exact Sciences Corporation Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Precision Oncology Introduction
11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2020-2025)
11.4.5 Illumina, Inc. Recent Development
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Details
11.5.2 Invitae Corporation Business Overview
11.5.3 Invitae Corporation Precision Oncology Introduction
11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2020-2025)
11.5.5 Invitae Corporation Recent Development
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Details
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Precision Oncology Introduction
11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025)
11.6.5 Laboratory Corporation of America Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Precision Oncology Introduction
11.7.4 QIAGEN Revenue in Precision Oncology Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Rain Oncology
11.8.1 Rain Oncology Company Details
11.8.2 Rain Oncology Business Overview
11.8.3 Rain Oncology Precision Oncology Introduction
11.8.4 Rain Oncology Revenue in Precision Oncology Business (2020-2025)
11.8.5 Rain Oncology Recent Development
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Details
11.9.2 Relay Therapeutics Business Overview
11.9.3 Relay Therapeutics Precision Oncology Introduction
11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2020-2025)
11.9.5 Relay Therapeutics Recent Development
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Details
11.10.2 Strata Oncology, Inc. Business Overview
11.10.3 Strata Oncology, Inc. Precision Oncology Introduction
11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025)
11.10.5 Strata Oncology, Inc. Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Details
11.12.2 Variantyx, Inc. Business Overview
11.12.3 Variantyx, Inc. Precision Oncology Introduction
11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025)
11.12.5 Variantyx, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Precision Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Precision Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Precision Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Precision Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Precision Oncology Market Share by Region (2020-2025)
Table 8. Global Precision Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Precision Oncology Market Share by Region (2026-2031)
Table 10. Precision Oncology Market Trends
Table 11. Precision Oncology Market Drivers
Table 12. Precision Oncology Market Challenges
Table 13. Precision Oncology Market Restraints
Table 14. Global Precision Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Precision Oncology Market Share by Players (2020-2025)
Table 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Table 17. Ranking of Global Top Precision Oncology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Precision Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Precision Oncology, Headquarters and Area Served
Table 20. Global Key Players of Precision Oncology, Product and Application
Table 21. Global Key Players of Precision Oncology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Precision Oncology Revenue Market Share by Type (2020-2025)
Table 25. Global Precision Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Precision Oncology Revenue Market Share by Type (2026-2031)
Table 27. Global Precision Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Precision Oncology Revenue Market Share by Application (2020-2025)
Table 29. Global Precision Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Precision Oncology Revenue Market Share by Application (2026-2031)
Table 31. North America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Precision Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Precision Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Precision Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Acrivon Therapeutics Company Details
Table 47. Acrivon Therapeutics Business Overview
Table 48. Acrivon Therapeutics Precision Oncology Product
Table 49. Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 50. Acrivon Therapeutics Recent Development
Table 51. Bio-Serv Company Details
Table 52. Bio-Serv Business Overview
Table 53. Bio-Serv Precision Oncology Product
Table 54. Bio-Serv Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 55. Bio-Serv Recent Development
Table 56. Exact Sciences Corporation Company Details
Table 57. Exact Sciences Corporation Business Overview
Table 58. Exact Sciences Corporation Precision Oncology Product
Table 59. Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 60. Exact Sciences Corporation Recent Development
Table 61. Illumina, Inc. Company Details
Table 62. Illumina, Inc. Business Overview
Table 63. Illumina, Inc. Precision Oncology Product
Table 64. Illumina, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 65. Illumina, Inc. Recent Development
Table 66. Invitae Corporation Company Details
Table 67. Invitae Corporation Business Overview
Table 68. Invitae Corporation Precision Oncology Product
Table 69. Invitae Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 70. Invitae Corporation Recent Development
Table 71. Laboratory Corporation of America Company Details
Table 72. Laboratory Corporation of America Business Overview
Table 73. Laboratory Corporation of America Precision Oncology Product
Table 74. Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 75. Laboratory Corporation of America Recent Development
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Precision Oncology Product
Table 79. QIAGEN Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 80. QIAGEN Recent Development
Table 81. Rain Oncology Company Details
Table 82. Rain Oncology Business Overview
Table 83. Rain Oncology Precision Oncology Product
Table 84. Rain Oncology Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 85. Rain Oncology Recent Development
Table 86. Relay Therapeutics Company Details
Table 87. Relay Therapeutics Business Overview
Table 88. Relay Therapeutics Precision Oncology Product
Table 89. Relay Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 90. Relay Therapeutics Recent Development
Table 91. Strata Oncology, Inc. Company Details
Table 92. Strata Oncology, Inc. Business Overview
Table 93. Strata Oncology, Inc. Precision Oncology Product
Table 94. Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 95. Strata Oncology, Inc. Recent Development
Table 96. Thermo Fisher Scientific Inc. Company Details
Table 97. Thermo Fisher Scientific Inc. Business Overview
Table 98. Thermo Fisher Scientific Inc. Precision Oncology Product
Table 99. Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 100. Thermo Fisher Scientific Inc. Recent Development
Table 101. Variantyx, Inc. Company Details
Table 102. Variantyx, Inc. Business Overview
Table 103. Variantyx, Inc. Precision Oncology Product
Table 104. Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 105. Variantyx, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Precision Oncology Picture
Figure 2. Global Precision Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Oncology Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Therapeutics Features
Figure 6. Global Precision Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Precision Oncology Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Hospitals & Diagnostic Laboratories Case Studies
Figure 10. Healthcare Data Companies Case Studies
Figure 11. Precision Oncology Report Years Considered
Figure 12. Global Precision Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Precision Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Precision Oncology Market Share by Region: 2024 VS 2031
Figure 15. Global Precision Oncology Market Share by Players in 2024
Figure 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Precision Oncology Revenue in 2024
Figure 18. North America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Precision Oncology Market Share by Country (2020-2031)
Figure 20. United States Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Precision Oncology Market Share by Country (2020-2031)
Figure 24. Germany Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Precision Oncology Market Share by Region (2020-2031)
Figure 32. China Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Precision Oncology Market Share by Country (2020-2031)
Figure 40. Mexico Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Precision Oncology Market Share by Country (2020-2031)
Figure 44. Turkey Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Acrivon Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 48. Bio-Serv Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 49. Exact Sciences Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 50. Illumina, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 51. Invitae Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 52. Laboratory Corporation of America Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 53. QIAGEN Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 54. Rain Oncology Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 55. Relay Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 56. Strata Oncology, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 58. Variantyx, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Precision Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Precision Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Precision Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Precision Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Precision Oncology Market Share by Region (2020-2025)
Table 8. Global Precision Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Precision Oncology Market Share by Region (2026-2031)
Table 10. Precision Oncology Market Trends
Table 11. Precision Oncology Market Drivers
Table 12. Precision Oncology Market Challenges
Table 13. Precision Oncology Market Restraints
Table 14. Global Precision Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Precision Oncology Market Share by Players (2020-2025)
Table 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Table 17. Ranking of Global Top Precision Oncology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Precision Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Precision Oncology, Headquarters and Area Served
Table 20. Global Key Players of Precision Oncology, Product and Application
Table 21. Global Key Players of Precision Oncology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Precision Oncology Revenue Market Share by Type (2020-2025)
Table 25. Global Precision Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Precision Oncology Revenue Market Share by Type (2026-2031)
Table 27. Global Precision Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Precision Oncology Revenue Market Share by Application (2020-2025)
Table 29. Global Precision Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Precision Oncology Revenue Market Share by Application (2026-2031)
Table 31. North America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Precision Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Precision Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Precision Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Precision Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Precision Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Precision Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Acrivon Therapeutics Company Details
Table 47. Acrivon Therapeutics Business Overview
Table 48. Acrivon Therapeutics Precision Oncology Product
Table 49. Acrivon Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 50. Acrivon Therapeutics Recent Development
Table 51. Bio-Serv Company Details
Table 52. Bio-Serv Business Overview
Table 53. Bio-Serv Precision Oncology Product
Table 54. Bio-Serv Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 55. Bio-Serv Recent Development
Table 56. Exact Sciences Corporation Company Details
Table 57. Exact Sciences Corporation Business Overview
Table 58. Exact Sciences Corporation Precision Oncology Product
Table 59. Exact Sciences Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 60. Exact Sciences Corporation Recent Development
Table 61. Illumina, Inc. Company Details
Table 62. Illumina, Inc. Business Overview
Table 63. Illumina, Inc. Precision Oncology Product
Table 64. Illumina, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 65. Illumina, Inc. Recent Development
Table 66. Invitae Corporation Company Details
Table 67. Invitae Corporation Business Overview
Table 68. Invitae Corporation Precision Oncology Product
Table 69. Invitae Corporation Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 70. Invitae Corporation Recent Development
Table 71. Laboratory Corporation of America Company Details
Table 72. Laboratory Corporation of America Business Overview
Table 73. Laboratory Corporation of America Precision Oncology Product
Table 74. Laboratory Corporation of America Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 75. Laboratory Corporation of America Recent Development
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Precision Oncology Product
Table 79. QIAGEN Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 80. QIAGEN Recent Development
Table 81. Rain Oncology Company Details
Table 82. Rain Oncology Business Overview
Table 83. Rain Oncology Precision Oncology Product
Table 84. Rain Oncology Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 85. Rain Oncology Recent Development
Table 86. Relay Therapeutics Company Details
Table 87. Relay Therapeutics Business Overview
Table 88. Relay Therapeutics Precision Oncology Product
Table 89. Relay Therapeutics Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 90. Relay Therapeutics Recent Development
Table 91. Strata Oncology, Inc. Company Details
Table 92. Strata Oncology, Inc. Business Overview
Table 93. Strata Oncology, Inc. Precision Oncology Product
Table 94. Strata Oncology, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 95. Strata Oncology, Inc. Recent Development
Table 96. Thermo Fisher Scientific Inc. Company Details
Table 97. Thermo Fisher Scientific Inc. Business Overview
Table 98. Thermo Fisher Scientific Inc. Precision Oncology Product
Table 99. Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 100. Thermo Fisher Scientific Inc. Recent Development
Table 101. Variantyx, Inc. Company Details
Table 102. Variantyx, Inc. Business Overview
Table 103. Variantyx, Inc. Precision Oncology Product
Table 104. Variantyx, Inc. Revenue in Precision Oncology Business (2020-2025) & (US$ Million)
Table 105. Variantyx, Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Precision Oncology Picture
Figure 2. Global Precision Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Oncology Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Therapeutics Features
Figure 6. Global Precision Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Precision Oncology Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Hospitals & Diagnostic Laboratories Case Studies
Figure 10. Healthcare Data Companies Case Studies
Figure 11. Precision Oncology Report Years Considered
Figure 12. Global Precision Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Precision Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Precision Oncology Market Share by Region: 2024 VS 2031
Figure 15. Global Precision Oncology Market Share by Players in 2024
Figure 16. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Precision Oncology Revenue in 2024
Figure 18. North America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Precision Oncology Market Share by Country (2020-2031)
Figure 20. United States Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Precision Oncology Market Share by Country (2020-2031)
Figure 24. Germany Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Precision Oncology Market Share by Region (2020-2031)
Figure 32. China Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Precision Oncology Market Share by Country (2020-2031)
Figure 40. Mexico Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Precision Oncology Market Share by Country (2020-2031)
Figure 44. Turkey Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Precision Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Acrivon Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 48. Bio-Serv Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 49. Exact Sciences Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 50. Illumina, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 51. Invitae Corporation Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 52. Laboratory Corporation of America Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 53. QIAGEN Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 54. Rain Oncology Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 55. Relay Therapeutics Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 56. Strata Oncology, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 58. Variantyx, Inc. Revenue Growth Rate in Precision Oncology Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232